{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T07:20:42Z","timestamp":1698045642582},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[1987,5,1]],"date-time":"1987-05-01T00:00:00Z","timestamp":546825600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[1987,5]]},"DOI":"10.1007\/bf00296955","type":"journal-article","created":{"date-parts":[[2004,10,24]],"date-time":"2004-10-24T17:12:58Z","timestamp":1098637978000},"page":"89-90","source":"Crossref","is-referenced-by-count":7,"title":["Human liver debrisoquine 4-hydroxylase: test for specifity toward various monooxygenase substrates and model of the active site"],"prefix":"10.1007","volume":"60","author":[{"given":"Thomas","family":"Wolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Distlerath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark T.","family":"Worthington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Peter","family":"Guengerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1073\/pnas.81.23.7348","volume":"81","author":"LM Distlerath","year":"1984","unstructured":"Distlerath LM, Guengerich FP (1984) Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs using an antibody raised to the analogous rat enzyme. Proc Natl Acad Sci (USA) 81: 7348?7352","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198207010-00001","volume":"7","author":"M Eichelbaum","year":"1982","unstructured":"Eichelbaum M (1982) Defective oxidation of drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokinet 7: 1?22","journal-title":"Clin Pharmacokinet"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00498258609050245","volume":"16","author":"FP Guengerich","year":"1986","unstructured":"Guengerich FP, Distlerath LM, Reilly PEB, Wolff T, Shimada T, Umbenhauer DR, Martin MV (1986) Human liver cytochrome P-450 involved in polymorphisms of drug oxidation. Xenobiotica 16: 367?378","journal-title":"Xenobiotica"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"11734","DOI":"10.1016\/S0021-9258(18)67305-3","volume":"261","author":"J Gut","year":"1986","unstructured":"Gut J, Catin T, Dayer P, Kronbach T, Zanger U, Meyer UA (1986) Debrisoquine\/sparteine type polymorphism of drug oxidation: purification and characterization of two functionally different human liver cytochrome P-450 isozymes involved in impaired hydroxylation of the prototype substrate bufuralol. J Biol Chem 261: 11734?11743","journal-title":"J Biol Chem"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1021\/bi00307a039","volume":"23","author":"D Larrey","year":"1984","unstructured":"Larrey D, Distlerath LM, Dannan GA, Wilkinson GR, Guengerich FP (1984) Purification and characterization of the rat liver cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry 23: 2787?2795","journal-title":"Biochemistry"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/0006-2952(85)90553-2","volume":"34","author":"T Wolff","year":"1985","unstructured":"Wolff T, Strecker M (1985) Lack of relationship between debrisoquine 4-hydroxylation and other cytochrome P-450 dependent reactions in rat and human liver. Biochem Pharmacol 34: 2593?2598","journal-title":"Biochem Pharmacol"},{"key":"CR7","first-page":"301","volume":"7","author":"T Wolff","year":"1979","unstructured":"Wolff T, Deml E, Wanders H (1979) Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent monooxygenase activities. Drug Metab Dipos 7: 301?305","journal-title":"Drug Metab Dipos"},{"key":"CR8","first-page":"2116","volume":"45","author":"T Wolff","year":"1985","unstructured":"Wolff T, Distlerath LM, Worthington MT, Groopman JD, Mammons GJ, Kadlubar FF, Prough RA, Martin MM, Guengerich FP (1985) Substrate specificity of human liver cytochrome P-450 debrisoquine hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Res 45: 2116?2122","journal-title":"Cancer Res"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00296955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00296955\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00296955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T22:26:51Z","timestamp":1624746411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00296955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,5]]},"references-count":8,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[1987,5]]}},"alternative-id":["BF00296955"],"URL":"https:\/\/doi.org\/10.1007\/bf00296955","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,5]]}}}